COVID-19 Vaccine and Boosters Update From ODP

ODP Announcement 22-105 provides the most recent update to recommendations from the Centers for Disease Control (CDC) about details for COVID-19 vaccine and boosters. Release of this announcement will obsolete “ODPANN 22-046: COVID-19 Vaccine Booster Reminder.”

This updated guidance includes information on newly available booster vaccines, which are referred to as bivalent or updated vaccines. The guidance also discusses the availability of a newer primary vaccine called the Novavax COVID-19 vaccine. The CDC has updated information regarding the vaccination schedule for individuals based on age and provides considerations based on additional factors. Full information is available at the CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States.